- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02202369
Multimodal Analgesia vs. Routine Care Pain Management for Lumbar Spine Fusion Surgery: A Prospective Randomized Study
Study Overview
Status
Intervention / Treatment
Detailed Description
Specific Aim #1: To compare the postoperative pain levels of single level lumbar fusion patients treated with either MMA pain management protocol or standard pain management protocol.
Controlling postoperative pain is a critical first step in facilitating a patient's recovery and improved quality of life. In-hospital pain levels will be measured using a numeric pain scale on a scale of 0-10. Pain assessment is conducted by the hospital nurses as a standard of care protocol. Assessments are every four to six hours, within 60 minutes after receiving a pain medication
Hypothesis: Patients treated with the MMA pain protocol will have significantly less immediate postoperative pain as compared to patients treated with the standard pain protocol.
Specific Aim #2: To compare the immediate postoperative, or in-hospital, narcotic consumption of single level lumbar fusion patients treated with either MMA pain management protocol or standard pain management protocol.
Decreasing narcotic consumption following lumbar spinal fusion surgery is important for faster recovery for the patient, decreasing narcotic related side effects (nausea and vomiting, lethargy, ileus, etc) as well as lowering overall treatment costs. The total amount of narcotic use during the course of the hospitalization for each subject will be recorded. Dosages of narcotics will be converted to morphine equivalents.
Hypothesis: Patients treated with the MMA pain protocol will consume significantly less immediate postoperative narcotic pain medications compared to patients treated with the standard pain protocol.
Specific Aim #3: To compare the length of hospital stay of single level lumbar fusion patients treated with either MMA pain management protocol or standard pain management protocol.
Decreasing the amount of time patients remain in the hospital may decrease the time it takes a patient to return to personal and societal responsibilities. Additionally it reduces the patients risk of a nosocomial infection and reduces the costs of the surgery.
Hypothesis: Patients treated with the MMA pain protocol will have a significantly reduced length of stay in the hospital compared to patients treated with the standard pain protocol.
Specific Aim #4: To compare postoperative quality of life of single level lumbar fusion patients treated with either MMA pain management protocol or standard pain management protocol.
The primary purpose of lumbar fusion surgery is to improve the quality of life for patients. The Oswestry Disability Index (ODI) will be used as a disease specific measure. The Veterans Rand 12 (VR-12) will be used as a general health outcome measure. Each of these patient reported outcome measures will be collected pre-operatively and at each of the following postoperative visits: 2 weeks, 6 weeks, 3 month, 6 visit, 1 visit, and 2 year.
Hypothesis: Patients treated with the MMA pain protocol will have significantly greater improvement in Quality of Life measures compared to patients treated with the standard pain protocol and this will be sustained out to two years post-operatively.
Study Type
Enrollment (Actual)
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
North Carolina
-
Charlotte, North Carolina, United States, 28207
- OrthoCarolina
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Subjects undergoing a single level lumbar decompression and fusion
- > 18 years of age and < 70 years of age
- The subject is willing and able to understand, sign and date the study specific patient informed consent and HIPAA authorization to volunteer participation in the study
Exclusion Criteria:
- Patients with liver disease (documented liver function test abnormality)
- Patients with renal disease (documented glomerular filtration rate < 60mL/min/1.73m2)
- Patients with a baseline (pre-operative) opioid use greater than 30 mg of morphine equivalents/day.
- Patients with active alcohol dependence
- Patients with active illicit drug dependence
- Patients < 18 years of age and >70 years of age
- Patients allergic to any medication given in either arm (list medications)
- Patients who have a seizure disorder
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Multimodal Analgesia (MMA) Treatment
|
Subjects are given medications preop (Pregabalin, Oxycodone, Acetaminophen, Transdermal Scopolamine, Cyclobenzaprine), intraop (Propofol induction, Sevoflorane maintenance, Dexamethasone, Fentanyl, Ketamine, Marcaine, Zofran) and postop(Acetaminophen, Pregabalin, Tramadol, Cyclobenzaprine) that implement a multi-modal approach to managing pain.
|
Active Comparator: Standard of Care Pain Managment Protocol
|
Subjects will be treated with patient controlled (standard of care) narcotic analgesia for pain management.
(Marcaine, Dexamethasone, Zofran, Morphine, Acetaminophen, Cyclobenzaprine)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Patient reported pain level using a verbal numeric pain scale (NPS)
Time Frame: In hospital (participants will be followed for the duration of the hospital stay, an expected average of 2 days)
|
While in the hospital, patient's pain is assessed by a nurse-driven standard of care protocol.
Assessments are typically every four to six hours or within 60 minutes after receiving an intravenous or oral analgesic medication.
This assessment includes rating subjective rating of ones pain on a verbal numeric rating scale (NRS) of 0-10.
The maximum pain score for each post-operative day will be compared.
|
In hospital (participants will be followed for the duration of the hospital stay, an expected average of 2 days)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Patient satisfaction
Time Frame: In hospital (participants will be followed for the duration of the hospital stay, an expected average of 2 days)
|
As part of the nurse driven standard of care protocol, patients are asked if their pain level is acceptable during their stay in the hospital
|
In hospital (participants will be followed for the duration of the hospital stay, an expected average of 2 days)
|
Narcotic consumption
Time Frame: In hospital (participants will be followed for the duration of the hospital stay, an expected average of 2 days)
|
The total amount of narcotic use during the course of hospitalization for each subject will be recorded.
Dosages of narcotics will be converted to morphine equivalents
|
In hospital (participants will be followed for the duration of the hospital stay, an expected average of 2 days)
|
Length of stay
Time Frame: Hospital discharge (an expected average of 2 days after surgery)
|
The number of hours of hospitalization from entering the recovery room (time zero) until the patient meets discharge criteria
|
Hospital discharge (an expected average of 2 days after surgery)
|
Discharge destination
Time Frame: Hospital discharge (an expected average of 2 days after surgery)
|
As standard of care this data point will be documented in the patients chart.
It is categorized as patient home, rehabilitation facility, or skilled nursing facility
|
Hospital discharge (an expected average of 2 days after surgery)
|
Oswestry Disability Index (ODI)
Time Frame: pre-operative, 2 week post-operative, 6 week post-operative, 3 month post-operative, 6 month post-operative, 1 year post-operative, 2 year post-operative
|
A disease specific questionnaire
|
pre-operative, 2 week post-operative, 6 week post-operative, 3 month post-operative, 6 month post-operative, 1 year post-operative, 2 year post-operative
|
The Veterans Rand 12 (VR-12)
Time Frame: pre-operative, 2 week post-operative, 6 week post-operative, 3 month post-operative, 6 month post-operative, 1 year post-operative, 2 year post-operative
|
A general health questionnaire
|
pre-operative, 2 week post-operative, 6 week post-operative, 3 month post-operative, 6 month post-operative, 1 year post-operative, 2 year post-operative
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Alden Milam, MD, OrthoCarolina Research Institute, Inc.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 9080
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Single Level Lumbar Decompression and Fusion Spine Surgery
-
National Taiwan University HospitalRecruiting
-
AXIS Spine Center- a division of Northwest Specialty...IDAHO PANHANDLE HEALTH DISTRICTRecruitingCervical Fusion | Fusion of Spine | Lumbar Fusion | Revision Spine SurgeryUnited States
-
Sklifosovsky Institute of Emergency CareRecruitingSpine Fusion | Spine Fracture | Thoracic Spine Fracture | Thoracolumbar Burst Fracture | Lumbar; Spine, Fracture | Fracture of Spine, Level UnspecifiedRussian Federation
-
Tanta Universitymona bologh elmorad,MD; mohmed naser shaddad,MDCompletedDouble Level Lumbar Spondylolisthesis (L3-L5) | Posterior Lumbar Interbody Fusion (PLIF) | Lumbar Fixation SurgeryEgypt
-
University of Southern CaliforniaTerminatedFusion of Spine, Lumbar RegionUnited States
-
Ilse van de WijgertRadboud University Medical CenterCompletedLumbar Disc Herniation | Lumbar Spinal Stenosis | Fusion of Spine | Spinal Fusion | Lumbar Spondylolisthesis | Spondylolisthesis | Lumbar Disc Disease | Lumbar Spondylosis | Lumbar Spine Disease | Lumbar Radiculitis | Spondylosis Lumbosacral RegionNetherlands
-
Assuta Medical CenterUnknownSpinal Stenosis Lumbar | Spondylolisthesis | Degeneration Spine | Fusion of Spine, Lumbar RegionIsrael
-
University of Southern CaliforniaRecruitingPain, Postoperative | Spine Fusion | Lumbar Spine Degeneration | Lumbar Spine SpondylosisUnited States
-
Twin Cities Spine CenterNot yet recruitingLumbar Spondylolisthesis | Spine Fusion | Lumbar StenosisUnited States
-
Potsawat SurabotsoponNot yet recruitingSurgery | Disc Degeneration | Spinal Stenosis Lumbar | Fusion of Spine | Disc Disease
Clinical Trials on Multimodal Analgesia Treatment
-
Centre Hospitalier Universitaire de NīmesRecruiting
-
Rush University Medical CenterTerminatedSpinal Stenosis | Lumbar Spondylolisthesis | Degenerative Disc Disease LumbarUnited States
-
Gangnam Severance HospitalRecruitingCytoreductive Surgery | Hyperthermic Intra-peritoneal Chemotherapy | Peritoneal CancerKorea, Republic of
-
Hospital Clínico La FloridaUniversity of Valencia; University of Chile; Hospital San José; Hospital Provincia...Completed
-
University Medicine GreifswaldRecruiting
-
Nationwide Children's HospitalCompletedPatellofemoral SyndromeUnited States
-
Universidad de ZaragozaCompletedCarpal Tunnel SyndromeSpain
-
University of MalagaUnknownArm Lymphedema After Breast CancerSpain
-
Maastricht UniversityPfizer; Centrum voor Integrale Revalidatie (CIR)Active, not recruitingOsteoarthritis | Chronic Pain | Disability PhysicalNetherlands
-
JIANG Zhi-WeiPfizerUnknown